Data Transparency
Data transparency has emerged as a foundational principle in the landscape of modern data management, representing the proactive approach organizations must take to communicate openly about how they collect, store, use, and share data. This concept is deeply intertwined with data governance and transparency reporting, ensuring that stakeholders—be it consumers, partners, or regulators—can easily access and understand data practices. With the rapid increase in data usage and the evolution of privacy-enhancing technologies, organizations must prioritize clarity and accountability in their data handling processes. This situates data transparency not just as a best practice, but as a critical necessity for building trust in an era where data misuse and breaches are prevalent. The importance of data transparency cannot be overstated; it plays a key role in fostering trust between organizations and individuals by empowering data subjects with knowledge and control over their personal information. Currently, stringent regulations such as the General Data Protection Regulation (GDPR) and the California Consumer Privacy Act (CCPA) mandate transparency as a tool for compliance, driving companies toward enhanced data governance frameworks. By implementing robust audit trails and employing technologies like blockchain, organizations can ensure that their data transparency efforts contribute to improved decision-making, stakeholder satisfaction, and regulatory adherence. In this rapidly evolving digital landscape, data transparency is not only about compliance; it’s about creating an informed and loyal consumer base that feels valued and secure.
What motivated Brianne Dressen, a Utah mother and preschool teacher, to participate in the AstraZeneca COVID-19 vaccine trial?
Brianne Dressen was motivated to participate in the vaccine trial by multiple converging factors. She had healthcare professionals in her family who expressed serious concerns about COVID-19's initial variant, reporting alarming cases of clotting disorders and heart attacks in young people at hospitals. This personal testimony from trusted medical sources created genuine fear about the pandemic's severity. Additionally, the media environment amplified these concerns with apocalyptic messaging about potential societal collapse. As someone who was fully vaccinated along with her children, and married to a PhD chemist, Dressen viewed participation as following science and fulfilling civic duty. She was already predisposed to get vaccinated and saw the trial as an opportunity to help society emerge from the pandemic with minimal damage. Her decision was further reinforced when friends successfully participated in Moderna trials, making her receptive when AstraZeneca's clinic contacted her directly for screening.
Watch clip answer (04:23m)
VICE News
00:14 - 04:38
What happened to Brianne Dressen during the COVID-19 vaccine trials and how is she responding to her experience?
Brianne Dressen, a healthy school teacher and mother of two, volunteered to participate in COVID-19 vaccine trials but experienced severe traumatic side effects that dramatically changed her perspective on vaccines. Her negative experience was so significant that she transformed from being a vaccine proponent to becoming a critic and advocate for vaccine safety. As a result of her ordeal, Dressen is now pursuing legal action by filing a groundbreaking lawsuit against AstraZeneca that could potentially reshape the vaccine industry. She has also become an advocate through React19.org, working to raise awareness about vaccine injuries and pushing for greater transparency in public health decisions and policies.
Watch clip answer (00:48m)VICE News
00:06 - 00:54
What systemic failures occurred when government health agencies handled COVID vaccine injury reports during the trial phase?
Brianne Dressen reveals a troubling disconnect between private acknowledgment and public statements by health agencies. While the FDA and NIH were holding regular meetings and confirming COVID vaccine injuries in trial participants, these same officials simultaneously appeared in public media denying knowledge of such reactions. This represents a significant failure in transparency and accountability. Government agencies were internally documenting serious neurological complications from vaccine trials while publicly maintaining that vaccine safety concerns were unsubstantiated. The system allowed for the suppression of legitimate injury reports, creating a barrier between clinical evidence and public health communication. Such dual messaging undermines public trust and highlights the need for greater accountability in vaccine safety monitoring and reporting processes.
Watch clip answer (00:44m)
VICE News
41:59 - 42:44
What led to AstraZeneca's COVID-19 vaccine being pulled from consideration in the United States?
AstraZeneca's vaccine was removed from the U.S. market after trial participant Brianne Dressen and another person reported identical serious neurological complications to the National Institutes of Health in January 2021. Despite initial promises that the vaccine was safe and effective, these adverse events were not disclosed to participants during the trial phase. The NIH responded within 24 hours to their reports, and within 10 days, two significant actions occurred: AstraZeneca was pulled from consideration in the United States, and the NIH initiated a study to investigate neurological complications following COVID vaccines in general. This demonstrates how individual adverse event reports can directly impact regulatory decisions and public health policy.
Watch clip answer (01:22m)
VICE News
15:53 - 17:15
What adverse effects did Brianne Dressen experience after participating in the AstraZeneca COVID-19 vaccine trial?
Brianne Dressen experienced severe and immediate neurological complications after receiving the AstraZeneca COVID-19 vaccine during the phase three trial. Within an hour of injection, she developed tingling in her arm, followed by blurred and double vision, auditory distortions, and mobility issues including leg weakness that caused her to walk into doorways. Despite being assured of medical and financial support for research-related injuries, Dressen faced inadequate care from the pharmaceutical company. Her experience highlights critical gaps in vaccine trial participant support and the need for greater transparency in reporting adverse effects during clinical trials.
Watch clip answer (01:32m)
VICE News
05:22 - 06:54
What motivated Brianne Dressen to participate in the AstraZeneca COVID-19 vaccine trial, and what was her family's background regarding vaccines?
Brianne Dressen was motivated to participate in the AstraZeneca vaccine trial by her desire to help society and support her community in getting through the pandemic with minimal damage. Her family had a strong pro-science background - her children were fully vaccinated, and her husband is a PhD chemist. They had been "faithfully invested in helping society" and "following the science." Additionally, she was encouraged by friends who had successfully participated in the Moderna clinical trial without issues, which reinforced her confidence in contributing to the vaccine research effort.
Watch clip answer (00:37m)
VICE News
03:55 - 04:32